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Chlorinated dioxins and dibenzofurans,
henceforward jointly referred to as dioxins,
are highly toxic tricyclic aromatic com-
pounds, among others formed as by-prod-
ucts in the manufacture of herbicides and
during combustion of municipal and
industrial wastes (1,2). Rather high con-
centrations of these lipophilic compounds
have been detected in human milk, espe-
cially in the Netherlands, Belgium, and the
United Kingdom (3). This contamination
ofbreast milk is a reflection ofexposure of
humans to these compounds, mainly by
food. Meat, dairy products, and fish oils
are the main sources (4-6). Infants may be
exposed to high levels ofthese compounds
via breast-feeding. Fetuses can also be
exposed to dioxins because these xenobi-
otics pass through theplacental barrier (7).
Several animal studies have shown that
dioxins can influence plasma thyroid hor-
mone concentrations. Increased (8,9) and
decreased (8,10-15) thyroxine concentra-
tions have been described after administra-
tion of2,3,7,8-tetrachloro-p-dibenzodioxin
(2,3,7,8-TCDD), the most toxic dioxin.
Polychlorinated biphenyls (PCBs) have the
same effects on thyroid hormone concen-
trations (16). As an altered thyroid hor-
mone status in the newborn may influence
the maturation of the central nervous sys-
tem and have consequences for psychomo-
tor development (17), we began a study to
investigate thyroid hormone concentra-
tions in relation to dioxin concentrations
in breast milk in a population ofbreast-fed
infants.
Subjects
In the period June 1990-May 1991, 38
healthy, pregnant, Caucasian women gave
informed consent for us to study the effects
of pre- and postnatal exposure to dioxins
in their offspring, according to a protocol
approved by the medical ethical commit-
tees of the Academic Medical Centre and
Hospital De Heel. Of the 38 infants, 35
were born in the delivery room ofthe local
hospital; 3 were born at home under super-
vision ofa midwife.
The mothers were between the ages of
21 and 38 years (mean 29.0 years) and had
uneventful pregnancies without the use of
antithyrotic drugs or iodine-containing
compounds. None of them had a family
history of thyroid disease. All intended to
breast feed for at least 12 weeks; however,
in 11 women breast-feeding ceased 4 to 11
weeks after delivery. The infants were all
full-term, healthy babies with birth weights
above 2500 g.
Methods
Maternal venous blood samples were taken
just before or just after delivery. Immed-
iately after birth, cord blood was sampled.
Blood samples were taken from the infants
at ages 1 and 11 weeks by venipuncture,
shortly after feeding. All blood samples
were centrifuged within a few hours after
sampling, and the plasma was kept frozen
at -200C until analysis was performed.
In all plasma samples, we measured
total 3,3',5,5'-tetraiodo-L-thyronine (tT4)
and thyroxine-binding globulin (TBG)
concentrations. Additionally, concentra-
tions of thyrotropin (TSH) were deter-
mined in cord blood and in the surplus of
plasma taken 1 and 11 weeks after birth
(25, 26, and 30 samples, respectively). In
the remaining plasma of 25 cord blood
samples, we measured the concentrations
of total 3,5,3'-triiodothyronine (tT3), free
T4, (fT4), and 3,3',5'-triiodothyronine
(reverse T3. rT3). In 26 plasma samples
taken at the age of 11 weeks, tT3 concen-
trations were measured.
At the ages of 1 and 11 weeks urine
samples were collected to control for
iodine excretion. Samples were frozen at -
200C until analysis was performed.
Three weeks after delivery, two milk
samples were collected from each mother.
While the infant was suckling one breast,
the milk sample was taken from the other
breast with an electrical breast pump. The
breast was emptied as much as possible.
Each mother collected two milk samples
during 1 day, which were mixed thorough-
ly, pooled, and frozen at -200C until
analysis ofdioxins was performed.
We measured concentrations ofthe 17
most toxic congeners (7 dioxins and 10
dibenzofurans). The concentration ofeach
congener was multiplied by its toxicity
equivalency factor (TEF), which is the rel-
ative toxicity with regard to 2,3,7,8-
TCDD, the most toxic congener (18). By
summing these products, we calculated the
toxicity of a mixture and expressed it as
toxic equivalence (TEQ). In this study
chlorinated dioxin and dibenzofuran con-
centrations (summarized as dioxin concen-
trations) are expressed in ng TEQ/kg milk
fat.
At the end of the study, we calculated
the median dioxin concentration in milk
fat. The mother-infant couples with a
dioxin concentration below the median
were assigned to the low exposure group.
The others were assigned to the high expo-
sure group. We compared the measured
items between the low and high exposure
groups. Control groups were not available
because in Western Europe all individuals
are more or less exposed to dioxins. The
use of bottle-fed infants as controls was
considered inappropriate for three reasons.
First, because of the different social back-
grounds between women who decide to
breast feed and those who decide to bottle
feed, it is not possible to randomize be-
tween breast-feeding and bottle-feeding.
Second, when bottle feeding is started from
the first day of birth, no representative
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mate prenatal exposure. Third, the pro-
longed effects ofintrauterine exposure can-
not be excluded, and fourth, T4 and T3
concentrations are higher in breast-fed
infants compared to bottle-fed infants (19).
Analytical Methods
After freeze drying, the sample was spiked
with 17 13C-labeled dioxins and dibenzo-
furans. The sample was then soxhlet-
extracted with toluene for 24 hr. After
evaporating the toluene, the extracted
lipids were determined gravimetrically.
Blank and reference samples (cow's milk)
were run on a regular basis. Thereafter, a
two-step "clean-up" was done using an
activated carbon column followed by two
columns filled with AgNO3 on silica gel
and A1203 respectively (20). After concen-
trating the sample, we quantified it using
gas chromatography and mass spectrome-
try (HP 5970 GC, Kratos Concept MS).
We used a mixture of 13C-labeled dioxins
and dibenzofurans as an internal standard.
Blank controls were included. Quality of
measurements is under control of inter-
national round-robin studies.
Plasma concentrations oftT4, tT3, and
rT3 were determined using radioimmu-
noassay according to Chopra (21), Larsen
(22), and Wiersinga (23), respectively.
Concentrations of TBG and FT4 fractions
were determined using radioimmunoassay
diagnostic kits (Eiken Chemical Co and
Byk-Sangtec Diagnostica, respectively).
We determined TSH concentrations using
an immunoradiometric assay kit (Immu-
notech International). Plasma samples
taken 1 and 11 weeks after birth were
diluted 10 times before measuring TSH
concentrations. Iodine concentrations in
urine were measured according to
DeVijlder et al. (24).
We used the two-tailed, independent
Student's t-test to test the significance of
differences in measured items between the
low and the high exposure group.
Results
Five cord blood samples and nine maternal
blood samples were not available for analy-
sis due to problems with procedures in the
beginning of the study (one and four cord
blood samples and four and five maternal
samples in the low and high exposure
groups, respectively). From the samples
taken 11 weeks after birth, 4 were lost due
to technical errors (1 and 3 in the low and
high exposure groups, respectively); the
lost sample in the low exposure group
belonged to a child that had been switched
to bottle-feeding already; the 3 samples lost
in the high exposure group were from
completely breast-fed infants. Eleven
mothers prematurely ended breast-feeding
Table 1. Concentrations ofmeasured congeners inthe low and high exposure groups (ng/kg milkfat)
Mean + SEM
TEF Low exposure High exposure pa
2,3,7,8-TCDD 1 2.82 ± 0.30 4.39 ± 0.58 0.023
1,2,3,7,8-PeCDD 0.5 5.73 ± 0.54 15.17 ± 1.70 <0.001
1,2,3,4,7,8-HxCDD 0.1 1.05 ± 0.47 1.30 ± 1.10 0.839
1,2,3,6,7,8-HxCDD 0.1 32.67 ± 2.24 64.72 ± 5.17 <0.001
1,2,3,7,8,9-HxCDD 0.1 4.00 ± 0.30 8.76 ± 2.24 0.049
1,2,3,4,6,7,8-HpCDD 0.01 47.25 ± 6.75 59.13 ± 7.87 0.260
OCDD 0.001 272.08 ± 27.70 314.18 ± 36.03 0.361
2,3,7,8-TCDF 0.1 2.03 ± 1.30 1.76 ± 0.87 0.863
1,2,3,7,8-PeCDF 0.1 0.03 ± 0.02 0.24 ± 0.24 0.384
2,3,4,7,8-PeCDF 0.5 14.29 ± 1.04 29.46 ± 2.31 <0.001
1,2,3,4,7,8-HxCDF 0.1 4.21 ± 0.31 9.59 ± 1.11 <0.001
1,2,3,6,7,8-HxCDF 0.1 4.20 ± 0.36 8.01 ± 0.80 <0.001
1,2,3,7,8,9-HxCDF 0.1 1.82 ± 0.20 4.40 ± 0.75 0.003
2,3,4,6,7,8-HxCDF 0.1 BDL BDL
1,2,3,4,6,7,8-HpCDF 0.01 4.76 ± 0.60 7.01 ± 1.05 0.071
1,2,3,4,7,8,9-HpCDF 0.01 BDL BDL
OCDF 0.001 0.37 ± 0.11 1.99 ± 0.76 0.048
TEF,toxicity equivalency factor; BDL, below detection limit.
8Two-tailed, independent Student's t-test.
Table 2. Thyroid hormone and TSH concentrations compared between low and high exposure groups in
cord blood
Low exposure High exposure
Mean ± SEM N Mean± SEM N pa
tT4(nmoVI) 122.5 ± 4.1 18 134.3 ±4.8 15 0.071
TBG (nmol/l) 520.1 ± 27.2 18 589.5 ± 30.5 15 0.099
tT4/TBG 0.240 ± 0.007 18 0.232 ± 0.008 15 0.45
TSH (mU/l) 10.4 ± 1.3 14 11.9 ± 1.9 11 0.58
tT3(nmol/l) 1.22 ± 0.20 14 1.01 ± 0.07 11 0.34
fT4(pmoV/) 13.8 ±0.4 14 14.8 ±0.4 11 0.12
rT3(nmol/1) 2.33 ±0.31 14 2.51 ± 0.16 11 0.61
tTY/tT4 0.010± 0.001 14 0.008± 0.001 11 0.16
rT3/tT3 2.54 ± 0.48 14 2.58 ± 0.22 11 0.94
tT4,total3,3'5,5'-tetraiodo-L-thyronine; TBG,thyroxine-binding globulin; TSH,thyrotropin;tT3, 3,5,5'-tri-
iodothyronine; fT4,free 3,3',5,5'-tetraiodo-L-thyronine; rT3, reverse T3.
8Two-tailed, independent Student's t-test.
Table 3. Thyroid hormone and TSH concentrations compared between low and high exposure groups at
the age of 1 week
Low exposure High exposure
Mean ± SEM N Mean SEM N pa
tT4(nmol/L) 154.5 ± 6.3 19 178.7 ± 5.5 19 0.006
TBG (nmol/L) 532.6 ± 16.3 19 546.2 ± 19.1 19 0.59
tT4/TBG 0.291 ± 0.009 19 0.332 ± 0.011 19 0.006
TSH (mU/L) 2.93 ± 0.41 15 2.56 0.41 11 0.51
Iodide excretion 921 ± 98 18 879 ± 181 16 0.84
tT4, total 3,3',5,5'-tetraiodo-L-thyronine; TBG, thyroxine-binding globulin; TSH, thyrotropin; tT3, 3,5,3'-tri-
iodothyronine.
"Two-tailed, independent Student's t-test.
blodide urinary excretion in nmol iodine/mmol creatinine.
Table 4. Thyroid hormone and TSH concentrations compared between low and high exposure groups at
the age of 11 weeks
Low exposure High exposure
Mean t SEM N Mean t SEM N pa
tT4(nmol/l) 111.1 ±4.0 18 122.2± 3.0 16 0.033
TBG (nmol/l) 519.0 ± 29.4 18 500.7 ± 13.0 16 0.57
tT4ITBG 0.220 ±0.008 18 0.247 ±0.009 16 0.040
TSH(mU/l) 1.81 ±0.19 18 2.50± 0.26 12 0.044
tT3(nmoVl) 2.94± 0.13 16 2.90 ± 0.13 10 0.81
Iodide excretionb 971 ±99 17 1156 ±98 18 0.19
tT4, total 3,3',5,5'-tetraiiodo-L-thyronine; TBG, thyroxine-binding globulin; TSH, thyrotropin; tT3, 3,5,3'-tri-
iodothyronine.
"Two-tailed, independent Student's t-test.
blodide urinary excretion in nmol iodine/mmol creatinine.
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and had to switch to bottle-feeding (pow-
dered milk formula): 7 mothers after 5
weeks, two after 6 weeks, and 2 after 8
weeks (8 and 3 in the low and high expo-
sure groups, respectively).
Breast-milk dioxin concentrations were
between 8.7 and 28.0 ng TEQ/kg milk fat
(mean 18.6) in the low exposure group and
between 29.2 and 62.7 ngTEQ/kg milk fat
(mean 37.5) in the high exposure group.
This difference in dioxin concentration
between both groups was highly significant
(p<O.OOl). Also, when only milk samples of
mothers who breast fed for at least 11 weeks
were considered, the difference in dioxin
concentration was highly significant
(p<O.OO1). Concentrations of the 17 mea-
sured congeners in the milk fat are listed in
Table 1 for both exposure groups. Birth
weight and gestational age were similar in
both groups (3.64 ± 0.09 versus 3.65 ± 0.12
kg and 40.2 ± 0.3 versus 40.4 ± 0.3 weeks
in the low and high exposure groups,
respectively). Six women had a history of
cigarette smoking during pregnancy in the
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Table5. Change ofthyroid hormone and TSH concentrations between birth and 1 week after birth com-
pared between low and high exposure groups
Low exposure High exposure
Mean t SEM N Mean t SEM N pa
tT4(nmol/l) 28.6 t 5.6 18 45.7 t 6.8 15 0.063
TBG (nmol/l) 5.1 ± 22.1 18 -29.6 ± 30.7 15 0.37
tT4/TBG 0.049 ± 0.012 18 0.095± 0.015 15 0.024
TSH (mU/1) -7.5± 1.7 19 -9.2± 2.1 14 0.48
tT4,total 3,3',5,5'-tetraiiodo-L-thronine; TBG,thyroxine-binding globulin; TSH,thyrotropin.
Two-tailed, independent Studentvs t-test.
low exposure group versus one in the high
exposure group. Mean tT4 and TBG con-
centrations and tT4/TBG ratios were similar
in the mothers of both groups (data not
shown).
The mean concentrations ofhormones,
TBG, and ratios determined in plasma of
the infants at different times after birth are
listed in Tables 2-4. The mean tT4 concen-
trations at birth and 1 and 11 weeks after
birth were higher in the high exposure
group, but the difference was only signifi-
cant 1 and 11 weeks after birth (see Fig.
la,b). At these ages, the tT4/TBG ratio (as
Low High Low High
Figure 1. Distribution of total T4 concentrations and tT4/TBG ratios of the subjects in the low and high
exposure groups at the ages of 1 week (a,c) and 11 weeks (b,d). Each symbol represents one infant.
Mean concentrations were significantly different.
indication for fT4 concentrations) was also
significantly higher in the high exposure
group (see Fig. 1c,d). In addition, TSH
concentrations were significantly higher at
the age of 11 weeks in the high exposure
compared to the low exposure group (see
Fig. 2). At birth and 1 week after birth,
TSH concentrations were not significantly
different in both groups. Mean concentra-
tions of tT3, rT3 and f14 in cord plasma
and tT3 concentrations at the age of 11
weeks were not significantly different
between both exposure groups. Urinary
iodide excretion was similar in both expo-
sure groups at the ages of 1 and 11 weeks.
When only infants who were breast fed for
at least 11 weeks were considered, no signif-
icant differences in tT4, TBG, and TSH
concentrations could be found at the age of
11 weeks. However, the tT4/TBG ratio was
still significantly higher in the high exposure
group at this age [mean ± SEM are 0.211 ±
0.011 and 0.246 ± 0.012 (p = 0.047) in the
lowand high exposure group, respectively].
The increase of tT4, TBG, TSH, and
tT4/TBG ratio during the first week oflife
was compared between the high and low
exposure groups. As shown in Table 5, both
tT4 (p=0.063) and the tT4/TBG ratio (p =
0.024) increased more in the high exposure
group.
5 S ...e X m Si
_ 2
Low High
Figure 2. Distribution of TSH concentrations of
the subjects in the low and high exposure groups
at the age of 11 weeks. Each symbol represents
one infant. Mean concentrations were signifi-
cantly different.
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Discussion
Comparing two groups of neonates, one
with a relatively high exposure to dioxins
as determined by breast-milk dioxin con-
centrations and one with a relatively low
exposure, we observed that the mean tT4
concentrations and tT4/TBG ratios were
significantly higher at the ages of 1 and 11
weeks in the high exposure group. TSH
concentrations were only significantly
higher in the high exposure group at the
age of 11 weeks. These significant differ-
ences between both exposure groups were
preceded by a tendency for higher tT4 con-
centrations in cord plasma in the high
exposure group. Additionally, in the first
week of life, tT4 concentrations and the
tT4/TBG ratio increased more in the high
exposure group than in the low exposure
group.
When only infants that were breast fed
for at least 11 weeks were considered,
mean tT4 and TSH concentrations were
still higher in the high exposure group at
this age. However, the differences were no
longer significant. This can, at least in part,
be explained by the small number of
infants breast fed for 11 weeks. The
tT4/TBG ratios were still significantly
higher in the high exposure group, indicat-
ing that free T4 concentrations were higher
in this group.
The higher tT4 concentrations cannot
be explained by differences in gestational
age and birth weight because these were
similar in both groups of infants. Neither
can they be explained by the difference in
smoking habits ofthe mothers. In a study
of Meberg et al. (25), higher tT4 concen-
trations in cord serum were found in the
smoking group compared to the nonsmok-
ing group. In our study, six of the seven
smokers were in the low exposure group.
In animal studies, the effects ofdioxins
on the thyroid hormone concentrations
depend on the species tested. Exposure to
2,3,7,8-TCDD was followed by elevated
plasma tT4 concentrations in the guinea
pig (8) and by elevated tT4, tT3, and TSH
concentrations in the hamster (9). In the
rat, however, dioxin exposure caused a
decrease oftT4 concentrations (10,11-15),
while tT3 concentrations were unchanged
(13-15,26) or increased (9,10,13), and
TSH concentrations were elevated (10,12).
Although dioxins change circulating hor-
mone concentrations, rats were functional-
ly euthyroid after administration of
2,3,7,8-TCDD (27-29).
Despite the different response of tT4
concentrations between hamsters and rats,
both species had increased TSH concentra-
tions after exposure to 2,3,7,8-TCDD
(10,12). Therefore, it is expected that in
both species the thyroid gland is stimulated
to increase T4 synthesis. Reduced tT4 con-
centrations in rats might be due to en-
hanced biliary excretion of T4 by induc-
tion of uridine diphosphate-glucuronyl-
transferase (UDP-glucuronyltransferase) by
the relatively high dose ofTCDD adminis-
tered. Induction of UDP-glucuronyltrans-
ferase, considered to be the rate-limiting
enzyme for biliary T4 excretion (30), has
been observed for both dioxins (10) and
PCBs (31). In hamsters, UDP-glucuronyl-
transferase is also induced, but absolute
activities, expressed on the basis of whole
livers, are about to fold lower than in rats
(95. Therefore, the biliary excretion ofT4
in hamsters will be less induced, so that
tT4 concentrations can rise as a response of
increased stimulation ofthe thyroid gland.
Regarding the results of the present
study, we postulate that dioxins influence
thyroid hormone concentrations in infants
by interfering with the thyroid hormone
regulatory system. First, the TBG concen-
trations are similar in both exposure
groups, indicating that dioxins do not
affect concentrations of the major thyrox-
ine-binding protein. Second, there are sig-
nificantly higher tT4 concentrations and
tT4/TBG ratios at the age of 1 and 11
weeks and higher TSH concentrations at
the age of 11 weeks in the high exposure
group. Because there is a structural similar-
ity between the dioxin molecule and T4
(32), dioxins might interfere with the
transport of T4 into the cell, the conver-
sion ofT4 into T3, or the binding ofT3 to
its nuclear receptor. In fact, an inhibition
ofthe enzyme 5'-deiodinase, which results
in decreased conversion of T4 to T3, has
been described by Rickenbacher et al. (33)
for dioxin analogs. We hypothesize that
dioxins might ultimately decrease the
nuclear T3 receptor occupancy. In the
pituitary gland, a decreased nuclear T3
receptor occupancy will stimulate TSH
secretion. The resulting higher T4 synthe-
sis will subsequently result in an adequate
receptor occupancy by T3, which compen-
sates for the action ofdioxins. In this way a
new steady state develops with increased
plasma concentrations of both tT4 and
TSH, resulting in functional euthyroidism
in this clinically healthy group ofinfants.
The significantly higher tT4 concentra-
tions and tT4/TBG ratios in the high
exposure group as compared to the low
exposure group at the age of 1 week can
hardly be explained by dioxin exposure via
breast milk alone because the intake of
milkduring the first week oflife is relative-
ly low. Additionally, there was already a
trend toward higher tT4 concentrations in
cord plasma. Considering the finding that
dioxins are present in fetal adipose tissue
and liver (7,34-37), we presume that the
higher tT4 concentrations result from
intrauterine exposure to these compounds,
although the role of exposure after birth
cannot be excluded. Dioxins are accumu-
lated in adipose tissue because of their
lipophilicity. In the first days of life, fatty
acids are mobilized from the brown adi-
pose tissue to maintain body temperature
(38). This may cause an increased release
of dioxins, resulting in circulating dioxin
concentrations high enough to affect the
target organs.
This importance ofprenatal exposure is
in accordance with the results ofsome epi-
demiologic studies in which prenatal expo-
sure to PCBs was related to disorders in
neurological development. Rogan et al.
(39) found a relation between transplacen-
tal exposure to PCBs and hypotonicity and
hyporeflexia in the first week oflife. A rela-
tion between in utero exposure to PCBs
and poorer short-term memory function at
the age of 4 years has been reported by
Jacobson et al. (40). In both studies, no
relation was found with postnatal exposure
by breast milk. This indicates that trans-
placental exposure to PCBs, although
smaller than exposure via breast milk, is
more important. Whether the neurological
disorders found by Rogan and Jacobson
are related to dioxin- or PCB-induced
changes in thyroid hormone concentra-
tions remains unclear.
The higher tT4 concentrations and
tT4/TBG ratios in the high exposure group
at the age of 11 weeks might be due to
prolonged effects of intrauterine exposure
to dioxins because ofthe long half-lives of
dioxins in humans (5-8 years) (41,42).
The fact that TSH concentrations were
significantly higher in this group suggests
that at 11 weeks the influence of dioxins
on the hypothalamic-pituitary-thyroid
axis has become even more pronounced. At
this age it is likely that, in addition to the
postulated long-term effects ofintrauterine
exposure to dioxins, exposure to these
compounds via breast milk may play a
role. However, the change in circulating
tT4 and TSH concentrations does not
prove that functional thyroid status has
been affected by pre- and postnatal expo-
sure to dioxins.
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